Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Other Accumulated Expenses (2020 - 2025)

Historic Other Accumulated Expenses for Bio-Techne (TECH) over the last 6 years, with Q4 2025 value amounting to $1.6 million.

  • Bio-Techne's Other Accumulated Expenses fell 4004.56% to $1.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.6 million, marking a year-over-year decrease of 4004.56%. This contributed to the annual value of $1.6 million for FY2025, which is 2352.39% down from last year.
  • According to the latest figures from Q4 2025, Bio-Techne's Other Accumulated Expenses is $1.6 million, which was down 4004.56% from $4.5 million recorded in Q3 2025.
  • In the past 5 years, Bio-Techne's Other Accumulated Expenses ranged from a high of $5.5 million in Q4 2021 and a low of $865000.0 during Q1 2023
  • Its 5-year average for Other Accumulated Expenses is $2.8 million, with a median of $2.6 million in 2021.
  • Its Other Accumulated Expenses has fluctuated over the past 5 years, first tumbled by 7587.34% in 2022, then soared by 24092.49% in 2024.
  • Quarter analysis of 5 years shows Bio-Techne's Other Accumulated Expenses stood at $5.5 million in 2021, then tumbled by 75.87% to $1.3 million in 2022, then skyrocketed by 220.32% to $4.2 million in 2023, then plummeted by 37.7% to $2.6 million in 2024, then tumbled by 40.05% to $1.6 million in 2025.
  • Its Other Accumulated Expenses stands at $1.6 million for Q4 2025, versus $4.5 million for Q3 2025 and $1.6 million for Q2 2025.